This article is more than 5 years old. Information may no longer be current.
Risk of hyperkalemia and organ transplant recipients
Click Here to Manage Email Alerts
Solid organ transplant recipients who develop hyperkalemia have an increased risk of mortality and 30-day readmissions, according to University of Cincinnati researchers led by Charuhas Thakar, MD.
“The study examined all acute care hospitalizations in transplant recipients based on a national cohort,” Thakar, professor and director of the UC Division of Nephrology Kidney CARE Program at the UC College of Medicine told Nephrology News & Issues.
After adjustment for major confounders, researchers analyzed the effect of hyperkalemia and its severity on in-hospital mortality/hospice discharge and 30-day readmissions.
Among approximately 15,000 solid organ transplant recipients, results showed 16% experienced hyperkalemia. Researchers found an overall in-hospital mortality of 2.6%, with a mortality rate of 6.1% and 2% in patients with vs. without hyperkalemia, respectively. Patients with hyperkalemia experienced an increased risk of death and 30-day readmissions, according to results. – by Casey Tingle
- Reference:
- Yamada M, et al. Abstract SA-OR034. Presented at: ASN Kidney Week; San Diego; Oct. 23-28, 2018.
Disclosure: Thakar reports that part of the research was supported by a fellowship grant award funded by Relypsa.